Artal Group S.A.

← Tracker

Institutional

CIK 0001053906

$1.01B

Reported AUM

Positions

Q1 2026

Period

2026-05-14

Filed

The Brief · Artal Group S.A. · Q1 2026

AI · grounded in 13F

Artal Group S.A. increased its position in Lexicon Pharmaceuticals Inc LXRX by 13.62%. The fund added one new position to its portfolio. Total assets under management stood at $1.01B with two total positions.

Portfolio · Q1 2026

Top holdings

#	Stock	Issuer	Price	Day %	1Y Gr.	5Y Gr.	Value	% of book	Δ shares (QoQ)	Status
1	CAVA	Cava Group Inc	$66.44	1.65%	-22.47%	14.45%	$769.2M	76.11%	—	HELD
2	LXRX	Lexicon Pharmaceuticals Inc	$2.34	0.86%	116.82%	-50.85%	$241.4M	23.89%	—	HELD

Source: SEC EDGAR · accession 0001053906-26-000006. 13F discloses long positions only — shorts, foreign equities, and options are excluded.